
Breast and lung cancers are considered much more ‘actionable’ than other cancers, due to the high number of targeted treatments approved in these settings.30
References
- Pao W, Hutchinson KE. Nat Med. 2012;18:349–351.
- Meldrum C, et al. Clin Biochem Rev. 2011;32:177–195.
- Schwaederle M, Kurzrock R. Oncoscience. 2015;2:779–780.
- Frampton GM, et al. Nat Biotechnol. 2013;31:1023–1031.
- Drilon A, et al. Clin Cancer Res. 2015;21:3631–3639.
- Hirsch FR, et al. Lancet. 2016;388:1012–1024.
- Baumgart M. Am J Hematol Oncol. 2015;11:10–13.
- Chakravarty D, et al. JCO Precis Oncol. 2017; doi: 10.1200/PO.17.00011.
- Global Oncology Trends Report 2018. Report by IQVIA Institute for Human Data Science. Available to download here (Accessed March 2019).
- Gagan J, Van Allen EM. Genome Med. 2015;7:80.
- Love-Koh J, et al. PharmacoEconomics. 2018;36:1439–1451.
- Lukong KE, et al. BBA Clinical. 2017;7:64–77.
- American Society of Clinical Oncology. Cancer Progress Timeline. Available at: https://www.asco.org/research-progress/cancer-progress-timeline
- Stratton MR, et al. Nature. 2009;458:719–724.
- Schrock AB, et al. Clin Cancer Res. 2016;22:3281–3285.
- Rankin A, et al. Oncologist. 2016;21:1306–1314.
- Suh JH, et al. Oncologist. 2016;21:684–691.
- Rizvi NA, et al. Science. 2015;348:124–128.
- Chalmers ZR, et al. Genome Med. 2017;9:34.
- Rosenburg JE, et al. Lancet. 2016;387:1909–1920.
- Goodman AM, et al. Mol Cancer Ther. 2017;16:2598–2608.
- Johnson DB, et al. Cancer Immunol Res. 2016;4:959–967.
- Rizvi H, et al. J Clin Oncol. 2018;36:633–641.
- Hellmann MD, et al. N Engl J Med. 2018;378:2093–2104.
- Le DT, et al. N Engl J Med. 2015;372:2509–2520.
- Hall MJ, et al. J Clin Oncol. 2016;30(15_suppl):1523.
- Mateo J, et al. Ann Oncol. 2018;29:1895–1902.
- National Cancer Institute. Targeted Cancer Therapies Fact Sheet. March 2019. Available at: https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheet
- Schwaederle M, et al. Mol Cancer Ther. 2016;15:743–752.
- Wall DP, Tonellato PJ. F1000 Med Rep. 2012;4:14.
- NHS England. Improving outcomes through personalised medicine. September 2016. https://www.england.nhs.uk/wp-content/uploads/2016/09/improving-outcomes-personalised-medicine.pdf
- Ettinger DS, et al. J Natl Compr Canc Netw. 2018;16:807–821.
- Lindeman NI, et al. J Mol Diagn. 2018;20:129–159.